| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |